Diabetes Mellitus in Saudi Arabia

Dawish, Mohamed Abdulaziz Al; Robert, Asirvatham Alwin

doi:10.1007/978-3-319-74365-3_45-1

Cited by 103 publications

(5 citation statements)

References 52 publications

(76 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some patients, particularly those with uncontrolled diabetes, developed a severe disease that needed hospitalization despite implementing strict prophylactic measures. Other studies reported similar observations [ 40 , 41 , 42 , 43 , 44 , 45 ]. Diabetes is a chronic disease associated with several metabolic, vascular, and immunologic abnormalities that can affect our response to pathogens.…”

Section: Discussionsupporting

confidence: 77%

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study

Kamal

Naghib

Daadour

et al. 2023

Viruses

View full text Add to dashboard Cite

To date, the effectiveness of COVID-19 vaccines and booster doses has yet to be evaluated in longitudinal head-to-head studies. This single-center longitudinal study assessed the effectiveness of ChAdOx1 nCoV-19, BNT162b2, and mRNA-1273 vaccines and assessed two BNT162b2 boosters in 1550 participants, of whom 26% had comorbidities. In addition, the SARS-CoV-2 antibody dynamics was monitored. A group of 1500 unvaccinated subjects was included as the controls. The study’s endpoint was the development of virologically-proven COVID-19 cases after vaccine completion, while the secondary endpoint was hospitalizations due to severe COVID-19. Overall, 23 (4.6%), 16 (3%), and 18 (3.8%) participants vaccinated with ChAdOx1 nCoV-19, BNT162b2, and mRNA-1273, respectively, developed COVID-19 after vaccine completion, with an effectiveness of 89%, 92%, and 90%. Ten COVID-19 cases were reported in participants with comorbidities, three of whom were hospitalized. No hospitalizations occurred after boosters. SARS-CoV-2 antibody levels peaked 2–4 weeks after the second vaccine dose but declined after a mean of 28.50 ± 3.48 weeks. Booster doses significantly enhanced antibody responses. Antibody titers ≤ 154 U/mL were associated with a higher risk of COVID-19 emergence. Thus, COVID-19 vaccines effectively reduced COVID-19 and prevented severe disease. The vaccine-induced SARS-CoV-2 antibody responses declined after 28–32 weeks. Booster doses induced significant maintained responses. SARS-CoV-2 antibody levels may help determine the timing and need for vaccine booster doses.

show abstract

Section: Discussionsupporting

confidence: 77%

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study

Kamal

Naghib

Daadour

et al. 2023

Viruses

View full text Add to dashboard Cite

show abstract

“…The survey questions were grounded in the theoretical framework of the study, which identified usability, technology, and user behaviour as the primary drivers of adoption intention. The study sample size was calculated based on a confidence level of 95% and a confidence interval of 5%; the total population is 11,662 of T1DM, and based on the statistics provided by [2], at least 372 responses we are required. Therefore, an accurate total sample of 873 was collected from the T1DM patients from King Khalid Hospital Saudi Arabia and Najran region.…”

Section: B Iot-cgm Adoption Concernsmentioning

confidence: 99%

“…A quarter of Saudi adults are expected to develop diabetes by 2030, with over half of Saudis over the age of 30 having diabetes or being at risk [1]. The solution to this issue lies in patients taking control of their healthcare and self-managing their blood sugar levels [2]. However, patients often lack the ability to follow physicians' advice on self-care management, necessitating the use of sophisticated technology.…”

mentioning

confidence: 99%

Type 1 Diabetes Mellitus Saudi Patients' Perspective on the Adopting IoT-Enabled CGM: Validation of Critical Factors in the IAI-CGM A Framework

Almansour,

Beloff,

White

2023

Annals of Computer Science and Information Systems

View full text Add to dashboard Cite

The increasing prevalence of diabetes, particularly in Saudi Arabia, calls for effective self-management tools to monitor blood sugar levels, such as Continuous Glucose Monitors. These are medical devices that can be used to track the glucose levels of people without a fingerstick blood sample. However, the adoption of IoT-enabled Continuous Glucose Monitors (IoT-CGM) can be challenging due to the use of new technology. This study proposes the Intention to Adopt IoTenabled Continuous Glucose Monitors (IAI-CGM) a framework, which incorporates practical, technological, and user behaviour considerations based on the Technology Acceptance Model (TAM). The study defines 8 hypotheses that are analysed using structural equation modelling. Data was collected; from 873 type 1 diabetes patients (T1DM) from Saudi Arabia. The model predicts the significant impact of all factors on adoption intent except technology -related self-efficacy (TRSE), enabling the assessment of Saudi T1DM patients for IoT-CGM readiness. Furthermore, the framework's novelty may serve as inspiration for developing comparable frameworks for wearable or attached health monitoring devices in patients with other illnesses and in other geographical locations.

show abstract

“…Type 2 Diabetes mellitus (T2DM) is a global epidemic [1], affecting 10.5% of adults around the world [2]. Additionally, 374 million individuals have impaired glucose tolerance, putting them at high risk of developing T2DM later in life [3]. The prevalence of T2DM has significantly increased particularly in high-income countries such as the Kingdom of Saudi Arabia (KSA) [4].…”

Section: Introductionmentioning

confidence: 99%

Evaluating the Use of Web-Based Technologies for Self-Management among Arabic-Speaking Immigrants Living with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Saudi Arabia

Althubyani,

Tang,

Thomas

et al. 2024

Diabetology

View full text Add to dashboard Cite

This study aimed to investigate the use of and willingness to adopt web-based technology for self-management of type 2 diabetes among Arabic-speaking immigrants in Saudi Arabia. Conducted in Taif in 2022, it involved participants with type 2 diabetes mellitus, utilizing a study-specific questionnaire to gather data on demographics, disease specifics, and attitudes towards using this technology for diabetes management. Out of the 109 individuals who responded, 91 completed the survey and reported accessing web-based technology and an average usage of two hours per day. The primary use was for social media (90.1%) and information searching (73.6%). The study found a high willingness to use web-based technology for dietary planning (85.7%), physical activity monitoring (94.5%), and communication with healthcare providers (93.41%). Notably, younger participants, those with higher education, and married individuals showed more inclination towards using such technology, as indicated by significant correlations (p < 0.001, CI = 0.03–0.38; p < 0.039, CI = 1.06–10.26; p = 0.024, CI = 1.23–19.74). Over half of the participants (56%) considered web-based technology beneficial for diabetes management, with many finding it time-saving (61.5%). In conclusion, a significant proportion of participants demonstrated a strong preference for integrating web-based technology into their diabetes self-management routines. This preference was particularly evident in key areas such as diet, physical activity, and glucose monitoring. These findings underscore the potential of web-based technologies in supporting effective diabetes management among Arabic-speaking immigrants, highlighting the need for targeted interventions that leverage these digital tools.

show abstract

Diabetes Mellitus in Saudi Arabia

Cited by 103 publications

References 52 publications

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study

Type 1 Diabetes Mellitus Saudi Patients' Perspective on the Adopting IoT-Enabled CGM: Validation of Critical Factors in the IAI-CGM A Framework

Evaluating the Use of Web-Based Technologies for Self-Management among Arabic-Speaking Immigrants Living with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Saudi Arabia

Contact Info

Product

Resources

About